Clinical Connection Home
  Welcome To
Clinical Connection
 

Trials
Alerts

Trials
Search

Health
Forum

Health
News

RSS

Intro

Clinics &
Sponsors

Member
Login
View Clinical Trial (Medical Research Study)

Effects of Diet Changes on Metabolism - NCT00523627-85014 (Clinical Trial 181774)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy181774.aspx



** Please review additional "Nearby Studies" on right ----->

This is an archived study that is no longer available, if you
would like to find active studies please search our studies.
Clinical Trials Notification
Clinical Trials Search

City:  Phoenix
State:  
AZ
Zip Code: 85014
Conditions: Obesity - Overnutrition
Purpose: This study, conducted at the NIH Clinical Research Unit at the Phoenix Indian Medical Center, will examine how the body's metabolism (energy expenditure) changes when people overeat and when they fast and how different diets (e.g., high-protein or high-fat) affect metabolism. The results may provide information about whether there are mechanisms that make some people more resistant than others to gaining weight when they eat more. Non-smoking healthy subjects between 18 and 55 years of age who weigh no more than 350 pounds may be eligible for this study. Participants undergo the following procedures: - Pregnancy test for women of childbearing age. - Oral glucose tolerance test. For this test, an I.V. line (needle attached to a plastic tube) is inserted into a vein to allow several blood draws without repeated needle sticks. After the first blood sample is drawn, the subject drinks a cola-flavored sugar solution. Five additional blood samples are then drawn over 3 hours. - Blood test for DNA (genetic) studies related to obesity, diabetes and related medical problems. - DEXA scan. This test measures body fat. The subject lies on a table while a very small dose of X-rays is passed through the body. - Respiratory chamber. This test measures how many calories the body burns a day and assesses energy balance between intake and expenditure. Subjects stay in a room with two windows, equipped with a sink, toilet, television and DVD player, desk, chair, telephone and bed for 24 hours. The test is repeated five times during the first 18-day admission and 3 times during the second 13-day admission. For the first two sessions, subjects are fed a diet equal to the amount of energy their body uses. For the next 6 stays they are fed double the amount of calories their body usually uses for 5 of the stays and fast (consume nothing but water and soda without caffeine or calories) during 1 stay. The overfeeding diets may be high or low in protein, normal in protein, or high in fat. Blood tests are done on the day of each respiratory chamber session and a 24-hour urine sample is collected for one day while in the chamber. - Eating behavior questionnaires. - Psychological performance tests. Some participants are asked to volunteer to repeat two of the chamber studies to validate the measurements. The repeat session includes only the fasting and the overfeeding with normal protein content. All participants are followed at 6 months with blood tests, a DEXA scan, and urine tests (including pregnancy test for women). At annual visits for years 1 through 7, participants have the 6-month tests plus an oral glucose tolerance test.
Study summary: Some people appear to be more resistant than others to gaining weight when they overeat, though they do not increase their physical activity. This may indicate that adaptive mechanisms exist, which lead to wasting as heat part of the excess calories taken in. Such mechanisms exist in rodents. Human studies have provided conflicting results. A pilot study on the relationship of the weight change over time with the changes in the amount of energy an individual uses over 24 hours (energy expenditure, EE) with 48-h overfeeding (OF) and fasting (F) in Pima Indian men has shown that persons with the greatest increase in EE with OF and the smallest decrease in EE with F gained the least weight over time, indicating that the ability to waste more calories when overfed may reduce weight gain. Other studies, however, have not shown such relationship. In addition, it has been proposed that unbalanced (namely low-protein) diets can help magnify these effects. The aims of this study are to test whether (a) the changes in EE in response to 24-h OF and F predict changes in weight over two years, and (b) low-protein and high-carbohydrate diets magnify the metabolic response to 24-h OF compared to normal protein and high-fat diets. 50 volunteers will be evaluated at baseline, 6 months and on a yearly basis for up to 7 years. At baseline, during two consecutive admissions 4 weeks or less apart, subjects will undergo 8 24-h sessions in a human respiratory chamber to measure EE while on a weight-maintaining diet, and then in random order F, 200% OF on a normal-protein diet, 200% OF on a low-protein diet, 200% OF on a high-carbohydrate, normal-protein diet, 200% OF on a high-carbohydrate, low-protein diet, and 200% OF on a high-fat, normal-protein diet . Body weight and composition will also be measured at each admission. Hormonal measurements to find determinants of adaptive changes in EE in response to OF and F will also be performed. This study will provide significant insights into possible mechanisms that may help people resist weight gain and obesity, as well as their determinants.
Criteria: - INCLUSION CRITERIA: - Age: 18-55 years, to exclude effects of aging on energy expenditure and weight change - Premenopausal - Weight: greater than or equal to 350 lb (maximum weight allowed on the DXA scanning tables by the manufacturer). EXCLUSION CRITERIA: History or clinical manifestation of: - Current smoking - Impaired glucose tolerance (IGT), type 1 and type 2 diabetes - Endocrine disorders, such as Cushing's disease, pituitary disorders, and hypo- and hyperthyroidism - Pulmonary disorders, including chronic obstructive pulmonary disease, which would limit ability to follow the protocol (investigator judgment) - Cardiovascular diseases, including coronary heart disease, heart failure, arrhythmias, and peripheral artery disease - Hypertension, as diagnosed and treated by an outside physician or by sitting blood pressure measurement, using an appropriate cuff, higher than 140/90 mmHg on two or more occasions - Liver disease, including cirrhosis, active hepatitis B or C, and AST or ALT greater than or equal to 3 times normal - Renal disease, as defined by serum creatinine concentrations greater than or equal to 1.5 mg/dl and/or proteinuria > 300 mg/day (200 microgram/min) - Central nervous system disease, including previous history of cerebrovascular accidents, dementia, and neurodegenerative disorders - Cancer requiring treatment in the past five years, except for non-melanoma skin cancers or cancers that have clearly been cured or in the opinion of the investigator carry an excellent prognosis (e.g., Stage 1 cervical cancer). - Infectious disease such as active tuberculosis, HIV (by self-report), chronic coccidiomycoses or other chronic infections that might influence weight. - Conditions not specifically mentioned above may serve as criteria for exclusion at the discretion of the investigators Alcohol and/or drug abuse (more than 3 drinks per day and use of drugs, such as amphetamines, cocaine, heroin, or marijuana). Pregnancy or lactation
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.

Data Source: ClinicalTrials.gov
Date Processed: November 3, 2009
Modifications to
this listing:
Only selected fields are shown, please use the link above to view all information about this clinical trial.

 
 
 
 
 
 
 
 












Clinical trials are medical research studies designed to test the safety and/or effectiveness of new drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.


Within 25 Miles

Type II Diabetes - Phoenix AZ

COPD (Chronic Obstructive Pulmonary Disease) - Phoenix AZ

Dry AMD-Age Macular Degeneration - Phoenix AZ

Type II Diabetes - Phoenix AZ

Alzheimer's Disease - Phoenix AZ

Lupus - Phoenix AZ

Irritable Bowel Syndrome with Constipation - Phoenix AZ

Type 2 Diabetes - Phoenix AZ

Type 2 Diabetes with Acute Coronary Syndrome - Phoenix AZ

Prevention of Gastric Ulcers in People Taking Aspirin Daily - Phoenix AZ

Ear Infection or Swimmer's Ear (Acute Bacterial Otitis Externa) - Phoenix AZ

Iron Deficiency Anemia - Phoenix AZ

IBS with Constipation - Phoenix AZ

Rheumatoid Arthritis (RA) - Paradise Valley AZ

H1N1 Flu Vaccine - Phoenix AZ

Type 2 Diabetes - North Phoenix AZ

High Blood Pressure (Hypertension) - North Phoenix AZ

Chronic Low Back Pain - Phoenix AZ

Osteoarthritis of the Knee - Phoenix AZ

Cholesterol - Tempe AZ

Osteoarthritis of the Knee - Tempe AZ

High Blood Pressure (Hypertension) - Tempe AZ

High Blood Pressure - Tempe AZ

Type II Diabetes - Tempe AZ

Type II Diabetes - Phoenix AZ

Restless Legs Syndrome - Phoenix AZ

Osteoporosis - North Phoenix AZ

Type 2 Diabetes - North Phoenix AZ

Schizophrenia - Chandler AZ

Schizophrenia - Chandler AZ

Irritable Bowel Syndrome with Constipation - Chandler AZ

Heartburn / GERD – Chandler AZ

Type II Diabetes - Chandler AZ

Type II Diabetes - Mesa AZ

Osteoporosis - Mesa AZ

H1N1 Flu Vaccine - Mesa AZ

Alzheimer's or Memory Loss Patients Currently Taking Namenda, Aricept, Exelon, or Razadyne - Litchfield Park AZ

Type 2 Diabetes - Mesa AZ

Alzheimer’s Disease – Gilbert AZ

Atrial Fibrillation - Gilbert AZ

Type II Diabetes - Gilbert AZ

Tinnitus (Ringing of the Ears) - Gilbert AZ

Gout - Gilbert AZ

High Cholesterol (Hypercholesterolemia) - Gilbert AZ

Type 2 Diabetes - Gilbert AZ

High Blood Pressure (Hypertension) - Gilbert AZ



Within 50 Miles



Within 100 Miles

 
Home | Clinical Trials Notification | Search Clinical Trials | About Clinical Trials | Message Board | Investigators
Links | Terms And Conditions | Sitemap | Suggestion/Feedback
© 1998-2009 | All trademarks are property of their legal owners. | All Rights Reserved

ClinicalConnection.com is a resource that provides individuals with information regarding clinical trials that are being conducted nationwide.
ClinicalConnection.com does not conduct these clinical trials nor endorse them. Please consult your doctor or physician before participating.